UWO23 Cells
USUSD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
一般資訊
| 說明 | The UWO23 (HPV33) cell line is derived from the tumor cells of a male patient with oral tongue cancer and is particularly notable for its expression of Human Papillomavirus type 33 (HPV33). This specific feature of UWO23 makes it a critical resource for research into the oncogenic roles of HPV in head and neck squamous cell carcinoma (HNSCC). The presence of HPV33 in these cells provides a unique opportunity to explore how this virus influences the carcinogenesis process, particularly in the context of oral and oropharyngeal regions. Research utilizing the UWO23 cell line focuses on uncovering the molecular and genetic interactions driven by HPV33 that lead to the development and progression of cancer. This includes studying alterations in cell cycle regulation, apoptosis resistance, and changes in cellular adhesion and motility, all of which are crucial for understanding tumor behavior and metastasis. Additionally, the UWO23 cell line is instrumental in the evaluation of new pharmacological treatments and potential diagnostic biomarkers for HPV-related cancers. By elucidating the pathways through which HPV33 contributes to malignancy, researchers can develop targeted therapies that might improve therapeutic outcomes for patients suffering from HPV-associated head and neck cancers. |
|---|---|
| 生物體 | Human |
| 組織 | Oral cavity; tongue |
| 疾病 | Squamous cell carcinoma of the oral tongue |
| 應用 | Generating Cisplatin Resistant HPV-positive HNSCC cell lines to study cisplatin resistance in HPV-positive cells |
| 同義詞 | University of Western Ontario 23 |
特徵
| 年齡 | 52 years |
|---|---|
| 性別 | Male |
| 生長特性 | Adherent |
監管數據
| 引用 | UWO23 (Cytion catalog number 300258) |
|---|---|
| 生物安全等級 | 2 |
| NCBI_TaxID | 9606 |
| Cellosaurus 編號 | CVCL_B7MF |
生物分子資料
| 病毒 | Transformant: Human papillomavirus type 33 (HPV33) |
|---|
處理方式
| 培養基 | DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) |
|---|---|
| 營養補充品 | Supplement the medium with 10% FBS |
| 解離試劑 | Accutase |
| 傳代培養 | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
品質控制與分子分析
| 不孕症 | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
分析證明書 (CoA)
| 批次編號 | 證書類型 | 日期 | 型號 |
|---|---|---|---|
| 300258-260324 | 分析證明書 | 23. May. 2025 | 300258 |
| 300258-111225 | 分析證明書 | 13. Mar. 2026 | 300258 |